Literature DB >> 11564784

Both CD34+38+ and CD34+38- cells home specifically to the bone marrow of NOD/LtSZ scid/scid mice but show different kinetics in expansion.

T C Kerre1, G De Smet, M De Smedt, F Offner, J De Bosscher, J Plum, B Vandekerckhove.   

Abstract

Human hemopoietic stem cells (HSC) have been shown to engraft, differentiate, and proliferate in the hemopoietic tissues of sublethally irradiated NOD/LtSZ scid/scid (NOD/SCID) mice. We used this model to study homing, survival, and expansion of human HSC populations from different sources or phenotype. We observed that CD34+ cells homed specifically to bone marrow (BM) and spleen, but by 3 days after injection, survived only in the BM. These BM-homed CD34+ cells proliferated intensively and gave rise to a 12-fold, 5.5-fold, and 4-fold expansion in 3 days for umbilical cord blood, adult mobilized peripheral blood, and adult BM-derived cells, respectively. By injection of purified subpopulations, it was demonstrated that both CD34+38+ and CD34+38- umbilical cord blood HSC homed to the BM and expanded. Importantly, kinetics of expansion were different: CD34+38+ cells started to increase in cell number from day 3 onwards, and by 4 wk after injection, virtually all CD34+ cells had disappeared. In contrast, CD34+38- cells remained quiescent during the first week and started to expand intensively from the third week on. In this paper, we have shown that homing, survival, and expansion of stem cells are three independent phenomena important in the early phase of BM engraftment and that kinetics of engraftment differ between CD34+38+ and CD34+38- cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564784     DOI: 10.4049/jimmunol.167.7.3692

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.

Authors:  Sylvia Snauwaert; Stijn Vanhee; Glenn Goetgeluk; Greet Verstichel; Yasmine Van Caeneghem; Imke Velghe; Jan Philippé; Zwi N Berneman; Jean Plum; Tom Taghon; Georges Leclercq; Kris Thielemans; Tessa Kerre; Bart Vandekerckhove
Journal:  Haematologica       Date:  2012-04-24       Impact factor: 9.941

2.  Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA).

Authors:  Mark Hills; Kai Lücke; Elizabeth A Chavez; Connie J Eaves; Peter M Lansdorp
Journal:  Blood       Date:  2009-04-09       Impact factor: 22.113

3.  The human chorion contains definitive hematopoietic stem cells from the fifteenth week of gestation.

Authors:  Marcus O Muench; Mirhan Kapidzic; Matthew Gormley; Alan G Gutierrez; Kathryn L Ponder; Marina E Fomin; Ashley I Beyer; Haley Stolp; Zhongxia Qi; Susan J Fisher; Alicia Bárcena
Journal:  Development       Date:  2017-03-02       Impact factor: 6.868

4.  Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.

Authors:  Chunyan Yang; Fangfang Chen; Ping Ren; Laren Lofchy; Chun Wan; Jingshi Shen; Guankui Wang; Hanmant Gaikwad; Jessica Ponder; Craig T Jordan; Robert Scheinman; Dmitri Simberg
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

5.  Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.

Authors:  Tâm D Quách; Thomas J Hopkins; Nichol E Holodick; Raja Vuyyuru; Tim Manser; Ruthee-Lu Bayer; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

6.  Efficient marking of human cells with rapid but transient repopulating activity in autografted recipients.

Authors:  Hanno Glimm; Manfred Schmidt; Marlene Fischer; Kerstin Schwarzwaelder; Manuela Wissler; Silke Klingenberg; Claudia Prinz; Cornelius F Waller; Winand Lange; Connie J Eaves; Christof von Kalle
Journal:  Blood       Date:  2005-04-21       Impact factor: 22.113

7.  Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers.

Authors:  Andre Larochelle; Michael Savona; Michael Wiggins; Stephanie Anderson; Brian Ichwan; Keyvan Keyvanfar; Sean J Morrison; Cynthia E Dunbar
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

8.  Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse.

Authors:  Hong Lin; Elisa De Stanchina; Xi Kathy Zhou; Yuhong She; Danthanh Hoang; Sandy Wy Cheung; Barrie Cassileth; Susanna Cunningham-Rundles
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14

Review 9.  Biology of normal and acute myeloid leukemia stem cells.

Authors:  John E Dick; Tsvee Lapidot
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

10.  Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Stephan Metz; Guido Piontek; Bernd Pichler; Marcus Settles; Ulrich Heinzmann; Jürgen Schlegel; Robert A J Oostendorp; Ernst J Rummeny
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.